Postmenopausal Osteoporosis
📧 Sign up to get email alerts when something new happens for Postmenopausal Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: A Study of Monthly Risedronate for Osteoporosis [Phase 3]
Phase 3 trial evaluating monthly risedronate for postmenopausal osteoporosis has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis [Phase 3]
Phase 3 results for a 35 mg delayed-release formulation of risedronate in postmenopausal osteoporosis have been posted following study compl…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease. [Phase 4]
Phase 4 trial comparing ibandronate (Bonviva) and alendronate on renal function in postmenopausal osteoporosis patients at high risk for kid…
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment [Phase 4]
Phase 4 trial evaluating Bonviva (ibandronate) in women with postmenopausal osteoporosis who previously received Bonviva; the study has comp…
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women [Phase 1]
Phase 1 study assessing safety, tolerability, pharmacokinetics and pharmacodynamics of oral PTH134 in postmenopausal women with osteoporosis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: A Study for Teriparatide in Severe Osteoporosis
A completed clinical trial evaluating teriparatide for severe osteoporosis has finished, sponsored by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis) [Phase 3]
This document reports results from a double-blind extension of the HORIZON Phase 3 trial evaluating zoledronic acid for fracture prevention …
-
FDA approval · 2011-04-06FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ALENDRONATE SODIUM from Aurobindo Pharma Limited, indicating approval of a supplemental submissi…
-
FDA approval · 2011-04-01FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for alendronate sodium filed by Amneal Pharmaceuticals of New York LLC. This action updates the regu…
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women [Phase 2]
Phase 2 trial comparing delayed-release versus immediate-release risedronate in postmenopausal osteoporosis has completed and posted results…
-
FDA approval · 2011-02-15FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Alendronate sodium filed by Aurobindo Pharma Limited.
-
FDA label_change · 2011-01-25FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Actonel (risendronate sodium) filed by Allergan, Inc., to update the labeling related to its app…
-
FDA approval · 2011-01-25FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Fosamax Plus D (alendronate sodium with cholecalciferol) from Organon LLC.
-
FDA approval · 2011-01-25FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for Atelvia (risendronate sodium), a delayed-release bisphosphonate, with updated label…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation [Phase 4]
A Phase 4 trial comparing risedronate and raloxifene for discontinuation of hormone replacement therapy in postmenopausal osteoporosis has b…
-
FDA approval · 2010-10-08FDA Approved: ATELVIA — Original Application (Allergan, Inc.)
FDA approved Atelvia (delayed-release risedronate sodium) under an original NDA from Allergan, for treatment of postmenopausal osteoporosis.
-
CLINICAL_TRIALS trial_result · 2010-08-03Clinical Trial Update: Study of Transitioning From Alendronate to Denosumab [Phase 3]
Phase 3 trial evaluating transitioning from alendronate to denosumab for postmenopausal osteoporosis, with results posted in August 2010.
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Motor Control Exercise in Osteoporotic Women [NA]
A clinical trial evaluating motor control exercise in osteoporotic, postmenopausal women has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-28Clinical Trial Update: Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density [Phase 2]
Phase 2 trial results assessing the efficacy, safety and tolerability of denosumab (AMG 162) in postmenopausal women with low bone mineral d…
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis [Phase 3]
Phase 3 trial comparing teriparatide to risedronate in women with spine fracture due to osteoporosis evaluated back pain outcomes. The study…
-
CLINICAL_TRIALS trial_result · 2010-06-14Clinical Trial Update: Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions [Phase 1]
This entry reports the completion of a Phase 1 bioequivalence study of Dr. Reddy's Alendronate Sodium 70 mg tablets under fasting conditions…
-
FDA approval · 2010-06-01FDA Approved: PROLIA — Original Application (Amgen, Inc)
The FDA approved PROLIA (denosumab) in its original application by Amgen, establishing its use for osteoporosis in postmenopausal women.
-
FDA approval · 2010-04-22FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ALENDRONATE SODIUM submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2010-01-28Clinical Trial Update: Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis [Phase 3]
A Phase 3 trial comparing arzoxifene with raloxifene in postmenopausal osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density [Phase 2]
Phase 2 multicenter randomized, placebo-controlled pilot study using microCT to estimate the effects of denosumab (AMG 162) and alendronate …